- Home
- BPMC vs ZWS Comparison
BPMC vs ZWS Comparison
Compare BPMC & ZWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- ZWS
- Stock Information
- Founded
- BPMC 2008
- ZWS 1892
- Country
- BPMC United States
- ZWS United States
- Employees
- BPMC N/A
- ZWS N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- ZWS Industrial Machinery/Components
- Sector
- BPMC Health Care
- ZWS Industrials
- Exchange
- BPMC Nasdaq
- ZWS Nasdaq
- Market Cap
- BPMC 6.7B
- ZWS 6.1B
- IPO Year
- BPMC 2015
- ZWS 2012
- Fundamental
- Price
- BPMC $111.96
- ZWS $38.84
- Analyst Decision
- BPMC Buy
- ZWS Buy
- Analyst Count
- BPMC 19
- ZWS 6
- Target Price
- BPMC $122.72
- ZWS $38.50
- AVG Volume (30 Days)
- BPMC 789.4K
- ZWS 940.4K
- Earning Date
- BPMC 02-13-2025
- ZWS 02-04-2025
- Dividend Yield
- BPMC N/A
- ZWS 0.93%
- EPS Growth
- BPMC N/A
- ZWS 24.05
- EPS
- BPMC N/A
- ZWS 0.79
- Revenue
- BPMC $434,415,000.00
- ZWS $1,552,600,000.00
- Revenue This Year
- BPMC $108.09
- ZWS $3.10
- Revenue Next Year
- BPMC $39.34
- ZWS $3.74
- P/E Ratio
- BPMC N/A
- ZWS $49.45
- Revenue Growth
- BPMC 100.93
- ZWS 2.55
- 52 Week Low
- BPMC $72.24
- ZWS $28.25
- 52 Week High
- BPMC $121.90
- ZWS $41.15
- Technical
- Relative Strength Index (RSI)
- BPMC 71.32
- ZWS 59.20
- Support Level
- BPMC $103.67
- ZWS $35.75
- Resistance Level
- BPMC $107.88
- ZWS $37.63
- Average True Range (ATR)
- BPMC 4.24
- ZWS 0.78
- MACD
- BPMC 2.43
- ZWS 0.23
- Stochastic Oscillator
- BPMC 97.93
- ZWS 92.24
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About ZWS Zurn Elkay Water Solutions Corporation
Zurn Elkay Water Solutions Corp designs procure, manufactures, and markets a range of clean water solutions for drinking water, hygiene, and sustainable water management. The Zurn Elkay product portfolio includes professional-grade water control and safety, water distribution and drainage, drinking water, finish plumbing, hygienic, environmental and site works products for public and private spaces.